68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-07

AUTHORS

Maarten Brom, Wim J. G. Oyen, Lieke Joosten, Martin Gotthardt, Otto C. Boerman

ABSTRACT

PURPOSE: Insulinomas are neuroendocrine tumours derived from pancreatic beta-cells. The glucagon-like peptide 1 receptor (GLP-1R) is expressed with a high incidence (>90%) and high density in insulinomas. Glucagon-like peptide 1 (GLP-1), the natural ligand of GLP-1R, is rapidly degraded in vivo. A more stable agonist of GLP-1R is exendin-3. We investigated imaging of insulinomas with DOTA-conjugated exendin-3 labelled with (68)Ga. METHODS: Targeting of insulinomas with [Lys(40)(DOTA)]exendin-3 labelled with either (111)In or (68)Ga was investigated in vitro using insulinoma tumour cells (INS-1). [Lys(40)((111)In-DTPA)]Exendin-3 was used as a reference in this study. In vivo targeting was investigated in BALB/c nude mice with subcutaneous INS-1 tumours. PET imaging was performed using a preclinical PET/CT scanner. RESULTS: In vitro exendin-3 specifically bound and was internalized by GLP-1R-positive cells. In BALB/c nude mice with subcutaneous INS-1 tumours a high uptake of [Lys(40)((111)In-DTPA)]exendin-3 in the tumour was observed (33.5 +/- 11.6%ID/g at 4 h after injection). Uptake was specific, as determined by coinjection of an excess of unlabelled [Lys(40)]exendin-3 (1.8 +/- 0.1%ID/g). The pancreas also exhibited high and specific uptake (11.3 +/- 1.0%ID/g). High uptake was also found in the kidneys (144 +/- 24%ID/g) and this uptake was not receptor-mediated. In this murine tumour model optimal targeting of the GLP-1R expressing tumour was obtained at exendin doses < or =0.1 microg. Remarkably, tumour uptake of (68)Ga-labelled [Lys(40)(DOTA)]exendin-3 was lower (8.9 +/- 3.1%ID/g) than tumour uptake of (111)In-labelled [Lys(40)(DTPA)]exendin-3 (25.4 +/- 7.2%ID/g). The subcutaneous tumours were clearly visualized by small-animal PET imaging after injection of 3 MBq of [Lys(40)((68)Ga-DOTA)]exendin-3. CONCLUSION: [Lys(40)((68)Ga-DOTA)]Exendin-3 specifically accumulates in insulinomas, although the uptake is lower than that of [Lys(40)((111)In-DTPA)]exendin-3. Therefore, [Lys(40)((68)Ga-DOTA)]exendin-3 is a promising tracer to visualize insulinomas with PET. More... »

PAGES

1345-1355

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-009-1363-y

DOI

http://dx.doi.org/10.1007/s00259-009-1363-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015567221

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20111963


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Transport", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gallium Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heterocyclic Compounds, 1-Ring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inhibitory Concentration 50", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lysine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Sequence Data", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pentetic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brom", 
        "givenName": "Maarten", 
        "id": "sg:person.01205210431.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205210431.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oyen", 
        "givenName": "Wim J. G.", 
        "id": "sg:person.0644704274.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644704274.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joosten", 
        "givenName": "Lieke", 
        "id": "sg:person.0645166147.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645166147.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gotthardt", 
        "givenName": "Martin", 
        "id": "sg:person.01031755146.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031755146.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boerman", 
        "givenName": "Otto C.", 
        "id": "sg:person.01265573040.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265573040.77"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.beem.2004.10.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002887372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-007-0450-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004095362", 
          "https://doi.org/10.1007/s00259-007-0450-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1536-1632(03)00038-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005545454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1536-1632(03)00038-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005545454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-003-1184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006099585", 
          "https://doi.org/10.1007/s00259-003-1184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-003-1184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006099585", 
          "https://doi.org/10.1007/s00259-003-1184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1460-9568.1995.tb00650.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011072477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1460-9568.1995.tb00650.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011072477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/gast.1997.v112.pm9024313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011996543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00181765", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016946247", 
          "https://doi.org/10.1007/bf00181765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-002-0761-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020985444", 
          "https://doi.org/10.1007/s00259-002-0761-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-004-1702-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024759795", 
          "https://doi.org/10.1007/s00259-004-1702-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-0115(94)90158-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028028591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0969-8051(98)00121-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036064842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002590050034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036382831", 
          "https://doi.org/10.1007/s002590050034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2965", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038947075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-006-0317-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039271748", 
          "https://doi.org/10.1007/s00259-006-0317-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-006-0317-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039271748", 
          "https://doi.org/10.1007/s00259-006-0317-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-007-0604-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048243461", 
          "https://doi.org/10.1007/s00259-007-0604-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0802045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052047724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2006.07.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053443027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/endo.130.1.1370150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064277220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2006-1479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064289463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1381612043383502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069165133"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3748/wjg.14.657", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071361038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077330948", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1632294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082559222"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-07", 
    "datePublishedReg": "2010-07-01", 
    "description": "PURPOSE: Insulinomas are neuroendocrine tumours derived from pancreatic beta-cells. The glucagon-like peptide 1 receptor (GLP-1R) is expressed with a high incidence (>90%) and high density in insulinomas. Glucagon-like peptide 1 (GLP-1), the natural ligand of GLP-1R, is rapidly degraded in vivo. A more stable agonist of GLP-1R is exendin-3. We investigated imaging of insulinomas with DOTA-conjugated exendin-3 labelled with (68)Ga.\nMETHODS: Targeting of insulinomas with [Lys(40)(DOTA)]exendin-3 labelled with either (111)In or (68)Ga was investigated in vitro using insulinoma tumour cells (INS-1). [Lys(40)((111)In-DTPA)]Exendin-3 was used as a reference in this study. In vivo targeting was investigated in BALB/c nude mice with subcutaneous INS-1 tumours. PET imaging was performed using a preclinical PET/CT scanner.\nRESULTS: In vitro exendin-3 specifically bound and was internalized by GLP-1R-positive cells. In BALB/c nude mice with subcutaneous INS-1 tumours a high uptake of [Lys(40)((111)In-DTPA)]exendin-3 in the tumour was observed (33.5 +/- 11.6%ID/g at 4 h after injection). Uptake was specific, as determined by coinjection of an excess of unlabelled [Lys(40)]exendin-3 (1.8 +/- 0.1%ID/g). The pancreas also exhibited high and specific uptake (11.3 +/- 1.0%ID/g). High uptake was also found in the kidneys (144 +/- 24%ID/g) and this uptake was not receptor-mediated. In this murine tumour model optimal targeting of the GLP-1R expressing tumour was obtained at exendin doses < or =0.1 microg. Remarkably, tumour uptake of (68)Ga-labelled [Lys(40)(DOTA)]exendin-3 was lower (8.9 +/- 3.1%ID/g) than tumour uptake of (111)In-labelled [Lys(40)(DTPA)]exendin-3 (25.4 +/- 7.2%ID/g). The subcutaneous tumours were clearly visualized by small-animal PET imaging after injection of 3 MBq of [Lys(40)((68)Ga-DOTA)]exendin-3.\nCONCLUSION: [Lys(40)((68)Ga-DOTA)]Exendin-3 specifically accumulates in insulinomas, although the uptake is lower than that of [Lys(40)((111)In-DTPA)]exendin-3. Therefore, [Lys(40)((68)Ga-DOTA)]exendin-3 is a promising tracer to visualize insulinomas with PET.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-009-1363-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2448270", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "name": "68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET", 
    "pagination": "1345-1355", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4a2b779e887cae5440dfe7af4512cae366c2dcf77dfe600265319954c2e7254e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20111963"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-009-1363-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015567221"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-009-1363-y", 
      "https://app.dimensions.ai/details/publication/pub.1015567221"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89789_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886138/"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1363-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1363-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1363-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1363-y'


 

This table displays all metadata directly associated to this object as RDF triples.

251 TRIPLES      21 PREDICATES      71 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-009-1363-y schema:about N203c52ffe5114e6eb775d24ebdc45631
2 N2110352cccea4f928bc796e2c7f2bb69
3 N30a581b22028469b86ef53b823236c2c
4 N329457453f0f42b38ec99d6ef1a34a5d
5 N36db3b27c0ee4eddb9786cbce245a3b9
6 N4f1c0fa41b4d484686b08d789121c571
7 N620ca757b9c54f539ccf82d423faa8a3
8 N7b4f7c5954c646c7a56e3061bf6ebb38
9 N87024cb0df794e1b93882ca771f14632
10 N938b0607dd9a4592b8a1f80c0ce12d5d
11 N9fe0669c19924293a571dde340197b34
12 Nb72f2b7569ad457e8fcb933c043421b5
13 Nc0571e5664944418b246c73fecdcd2d6
14 Nc51f5311372e437ea61975f3c8d94baf
15 Ncbfc02d7ae004a7f861c9825b091d08d
16 Ncf60ce42233242329e60f3abb12d2154
17 Nd2bc9a6deb1e4c149d3f6dedd2a3d97d
18 Nd83b58c363a54718a118a43ccaa0fd10
19 Ne198820a19824243bc357c333945cbb7
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N040d40530ac24a579910070fcd2acf44
23 schema:citation sg:pub.10.1007/bf00181765
24 sg:pub.10.1007/s00259-002-0761-1
25 sg:pub.10.1007/s00259-003-1184-3
26 sg:pub.10.1007/s00259-004-1702-y
27 sg:pub.10.1007/s00259-006-0317-x
28 sg:pub.10.1007/s00259-007-0450-1
29 sg:pub.10.1007/s00259-007-0604-1
30 sg:pub.10.1007/s002590050034
31 https://app.dimensions.ai/details/publication/pub.1077330948
32 https://doi.org/10.1016/0167-0115(94)90158-9
33 https://doi.org/10.1016/j.beem.2004.10.002
34 https://doi.org/10.1016/j.regpep.2006.07.005
35 https://doi.org/10.1016/s0969-8051(98)00121-8
36 https://doi.org/10.1016/s1536-1632(03)00038-6
37 https://doi.org/10.1053/gast.1997.v112.pm9024313
38 https://doi.org/10.1055/s-0038-1632294
39 https://doi.org/10.1056/nejmc0802045
40 https://doi.org/10.1111/j.1460-9568.1995.tb00650.x
41 https://doi.org/10.1158/1078-0432.ccr-06-2965
42 https://doi.org/10.1210/endo.130.1.1370150
43 https://doi.org/10.1210/jc.2006-1479
44 https://doi.org/10.2174/1381612043383502
45 https://doi.org/10.3748/wjg.14.657
46 schema:datePublished 2010-07
47 schema:datePublishedReg 2010-07-01
48 schema:description PURPOSE: Insulinomas are neuroendocrine tumours derived from pancreatic beta-cells. The glucagon-like peptide 1 receptor (GLP-1R) is expressed with a high incidence (>90%) and high density in insulinomas. Glucagon-like peptide 1 (GLP-1), the natural ligand of GLP-1R, is rapidly degraded in vivo. A more stable agonist of GLP-1R is exendin-3. We investigated imaging of insulinomas with DOTA-conjugated exendin-3 labelled with (68)Ga. METHODS: Targeting of insulinomas with [Lys(40)(DOTA)]exendin-3 labelled with either (111)In or (68)Ga was investigated in vitro using insulinoma tumour cells (INS-1). [Lys(40)((111)In-DTPA)]Exendin-3 was used as a reference in this study. In vivo targeting was investigated in BALB/c nude mice with subcutaneous INS-1 tumours. PET imaging was performed using a preclinical PET/CT scanner. RESULTS: In vitro exendin-3 specifically bound and was internalized by GLP-1R-positive cells. In BALB/c nude mice with subcutaneous INS-1 tumours a high uptake of [Lys(40)((111)In-DTPA)]exendin-3 in the tumour was observed (33.5 +/- 11.6%ID/g at 4 h after injection). Uptake was specific, as determined by coinjection of an excess of unlabelled [Lys(40)]exendin-3 (1.8 +/- 0.1%ID/g). The pancreas also exhibited high and specific uptake (11.3 +/- 1.0%ID/g). High uptake was also found in the kidneys (144 +/- 24%ID/g) and this uptake was not receptor-mediated. In this murine tumour model optimal targeting of the GLP-1R expressing tumour was obtained at exendin doses < or =0.1 microg. Remarkably, tumour uptake of (68)Ga-labelled [Lys(40)(DOTA)]exendin-3 was lower (8.9 +/- 3.1%ID/g) than tumour uptake of (111)In-labelled [Lys(40)(DTPA)]exendin-3 (25.4 +/- 7.2%ID/g). The subcutaneous tumours were clearly visualized by small-animal PET imaging after injection of 3 MBq of [Lys(40)((68)Ga-DOTA)]exendin-3. CONCLUSION: [Lys(40)((68)Ga-DOTA)]Exendin-3 specifically accumulates in insulinomas, although the uptake is lower than that of [Lys(40)((111)In-DTPA)]exendin-3. Therefore, [Lys(40)((68)Ga-DOTA)]exendin-3 is a promising tracer to visualize insulinomas with PET.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree true
52 schema:isPartOf N4891be6cae644d5286327f7ea76d717c
53 Nb54061713eef4f99af425ab5d3d95b33
54 sg:journal.1297401
55 schema:name 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
56 schema:pagination 1345-1355
57 schema:productId N062993ae70c145f48add2576ef2d7d9d
58 N0881168a9397401399c49f50132e0558
59 N2b7e7e9ad7104cb799988e75b6e28a62
60 N58753d35bd634ab8a54b216800dee61e
61 N909357e8fdc944ff90c604ef3996717e
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015567221
63 https://doi.org/10.1007/s00259-009-1363-y
64 schema:sdDatePublished 2019-04-11T09:51
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher N35589a2997c240938df781ebd4deb74a
67 schema:url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886138/
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N040d40530ac24a579910070fcd2acf44 rdf:first sg:person.01205210431.29
72 rdf:rest Nc27f881535b544819f4b551f3e99c503
73 N062993ae70c145f48add2576ef2d7d9d schema:name pubmed_id
74 schema:value 20111963
75 rdf:type schema:PropertyValue
76 N0881168a9397401399c49f50132e0558 schema:name readcube_id
77 schema:value 4a2b779e887cae5440dfe7af4512cae366c2dcf77dfe600265319954c2e7254e
78 rdf:type schema:PropertyValue
79 N203c52ffe5114e6eb775d24ebdc45631 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Mice
81 rdf:type schema:DefinedTerm
82 N2110352cccea4f928bc796e2c7f2bb69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Peptides
84 rdf:type schema:DefinedTerm
85 N2a7786f463d947e0b578c22084eda5d5 rdf:first sg:person.0645166147.38
86 rdf:rest N761dcce97aab4a259b3400b2bf6f7827
87 N2b7e7e9ad7104cb799988e75b6e28a62 schema:name doi
88 schema:value 10.1007/s00259-009-1363-y
89 rdf:type schema:PropertyValue
90 N30a581b22028469b86ef53b823236c2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Molecular Sequence Data
92 rdf:type schema:DefinedTerm
93 N329457453f0f42b38ec99d6ef1a34a5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Amino Acid Sequence
95 rdf:type schema:DefinedTerm
96 N35589a2997c240938df781ebd4deb74a schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N36db3b27c0ee4eddb9786cbce245a3b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Female
100 rdf:type schema:DefinedTerm
101 N4891be6cae644d5286327f7ea76d717c schema:volumeNumber 37
102 rdf:type schema:PublicationVolume
103 N4f1c0fa41b4d484686b08d789121c571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Animals
105 rdf:type schema:DefinedTerm
106 N58753d35bd634ab8a54b216800dee61e schema:name nlm_unique_id
107 schema:value 101140988
108 rdf:type schema:PropertyValue
109 N620ca757b9c54f539ccf82d423faa8a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Dose-Response Relationship, Drug
111 rdf:type schema:DefinedTerm
112 N6a7fa08ca37349adbe23c237f0cd8ee7 rdf:first sg:person.01265573040.77
113 rdf:rest rdf:nil
114 N761dcce97aab4a259b3400b2bf6f7827 rdf:first sg:person.01031755146.49
115 rdf:rest N6a7fa08ca37349adbe23c237f0cd8ee7
116 N7b4f7c5954c646c7a56e3061bf6ebb38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Gallium Radioisotopes
118 rdf:type schema:DefinedTerm
119 N87024cb0df794e1b93882ca771f14632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Biological Transport
121 rdf:type schema:DefinedTerm
122 N909357e8fdc944ff90c604ef3996717e schema:name dimensions_id
123 schema:value pub.1015567221
124 rdf:type schema:PropertyValue
125 N938b0607dd9a4592b8a1f80c0ce12d5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cell Line, Tumor
127 rdf:type schema:DefinedTerm
128 N9fe0669c19924293a571dde340197b34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Insulinoma
130 rdf:type schema:DefinedTerm
131 Nb54061713eef4f99af425ab5d3d95b33 schema:issueNumber 7
132 rdf:type schema:PublicationIssue
133 Nb72f2b7569ad457e8fcb933c043421b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Heterocyclic Compounds, 1-Ring
135 rdf:type schema:DefinedTerm
136 Nc0571e5664944418b246c73fecdcd2d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Inhibitory Concentration 50
138 rdf:type schema:DefinedTerm
139 Nc27f881535b544819f4b551f3e99c503 rdf:first sg:person.0644704274.30
140 rdf:rest N2a7786f463d947e0b578c22084eda5d5
141 Nc51f5311372e437ea61975f3c8d94baf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Lysine
143 rdf:type schema:DefinedTerm
144 Ncbfc02d7ae004a7f861c9825b091d08d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Kinetics
146 rdf:type schema:DefinedTerm
147 Ncf60ce42233242329e60f3abb12d2154 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Positron-Emission Tomography
149 rdf:type schema:DefinedTerm
150 Nd2bc9a6deb1e4c149d3f6dedd2a3d97d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Rats
152 rdf:type schema:DefinedTerm
153 Nd83b58c363a54718a118a43ccaa0fd10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Pentetic Acid
155 rdf:type schema:DefinedTerm
156 Ne198820a19824243bc357c333945cbb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Injections
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
163 schema:name Clinical Sciences
164 rdf:type schema:DefinedTerm
165 sg:grant.2448270 http://pending.schema.org/fundedItem sg:pub.10.1007/s00259-009-1363-y
166 rdf:type schema:MonetaryGrant
167 sg:journal.1297401 schema:issn 1619-7070
168 1619-7089
169 schema:name European Journal of Nuclear Medicine and Molecular Imaging
170 rdf:type schema:Periodical
171 sg:person.01031755146.49 schema:affiliation https://www.grid.ac/institutes/grid.10417.33
172 schema:familyName Gotthardt
173 schema:givenName Martin
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031755146.49
175 rdf:type schema:Person
176 sg:person.01205210431.29 schema:affiliation https://www.grid.ac/institutes/grid.10417.33
177 schema:familyName Brom
178 schema:givenName Maarten
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205210431.29
180 rdf:type schema:Person
181 sg:person.01265573040.77 schema:affiliation https://www.grid.ac/institutes/grid.10417.33
182 schema:familyName Boerman
183 schema:givenName Otto C.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265573040.77
185 rdf:type schema:Person
186 sg:person.0644704274.30 schema:affiliation https://www.grid.ac/institutes/grid.10417.33
187 schema:familyName Oyen
188 schema:givenName Wim J. G.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644704274.30
190 rdf:type schema:Person
191 sg:person.0645166147.38 schema:affiliation https://www.grid.ac/institutes/grid.10417.33
192 schema:familyName Joosten
193 schema:givenName Lieke
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645166147.38
195 rdf:type schema:Person
196 sg:pub.10.1007/bf00181765 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016946247
197 https://doi.org/10.1007/bf00181765
198 rdf:type schema:CreativeWork
199 sg:pub.10.1007/s00259-002-0761-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020985444
200 https://doi.org/10.1007/s00259-002-0761-1
201 rdf:type schema:CreativeWork
202 sg:pub.10.1007/s00259-003-1184-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006099585
203 https://doi.org/10.1007/s00259-003-1184-3
204 rdf:type schema:CreativeWork
205 sg:pub.10.1007/s00259-004-1702-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1024759795
206 https://doi.org/10.1007/s00259-004-1702-y
207 rdf:type schema:CreativeWork
208 sg:pub.10.1007/s00259-006-0317-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039271748
209 https://doi.org/10.1007/s00259-006-0317-x
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/s00259-007-0450-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004095362
212 https://doi.org/10.1007/s00259-007-0450-1
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/s00259-007-0604-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048243461
215 https://doi.org/10.1007/s00259-007-0604-1
216 rdf:type schema:CreativeWork
217 sg:pub.10.1007/s002590050034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036382831
218 https://doi.org/10.1007/s002590050034
219 rdf:type schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1077330948 schema:CreativeWork
221 https://doi.org/10.1016/0167-0115(94)90158-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028028591
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.beem.2004.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002887372
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.regpep.2006.07.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053443027
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0969-8051(98)00121-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036064842
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s1536-1632(03)00038-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005545454
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1053/gast.1997.v112.pm9024313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011996543
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1055/s-0038-1632294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082559222
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1056/nejmc0802045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052047724
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1111/j.1460-9568.1995.tb00650.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011072477
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1158/1078-0432.ccr-06-2965 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038947075
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1210/endo.130.1.1370150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064277220
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1210/jc.2006-1479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064289463
244 rdf:type schema:CreativeWork
245 https://doi.org/10.2174/1381612043383502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069165133
246 rdf:type schema:CreativeWork
247 https://doi.org/10.3748/wjg.14.657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071361038
248 rdf:type schema:CreativeWork
249 https://www.grid.ac/institutes/grid.10417.33 schema:alternateName Radboud University Nijmegen Medical Centre
250 schema:name Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
251 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...